Literature DB >> 8420931

Cell penetration of diphtheria toxin. Reduction of the interchain disulfide bridge is the rate-limiting step of translocation in the cytosol.

E Papini1, R Rappuoli, M Murgia, C Montecucco.   

Abstract

The pathway of cell penetration of diphtheria toxin (DT) was studied in Vero cells by following the kinetics of uptake, reduction, degradation, and sub-cellular distribution of 125I-DT in the absence or presence of bafilomycin A1 (baf-A1), a powerful inhibitor of the endosomal H(+)-ATPase. After a lag phase of 4 min, DT, bound to Vero cells, reached an acidic intracellular compartment, where about one-third of it underwent a transition to a state competent for subsequent reduction and membrane translocation. After further 4 min, this DT fraction was reduced in a baf-A1-insensitive reaction and DT-A, the intracellularly active protomer of DT, was immediately released in the cytosol. The present data indicate that cell-mediated reduction of the toxin is the rate-determining step of the DT cell intoxication process. Subcellular fractionation showed that DT underwent the low pH-driven conformational change in an early endosome, distinct from the subsequent endosomal compartment where reduction took place. DT-B remained endosome-bound and was proteolyzed at low pH as well as the portion of DT which was not reduced after the exposure to low pH in early endosomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420931

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step.

Authors:  S Contamin; A Galmiche; A Doye; G Flatau; A Benmerah; P Boquet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates.

Authors:  Cary D Austin; Xiaohui Wen; Lewis Gazzard; Christopher Nelson; Richard H Scheller; Suzie J Scales
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-01       Impact factor: 11.205

3.  Oxidized ATP protection against anthrax lethal toxin.

Authors:  Mahtab Moayeri; Katherine E Wickliffe; Jason F Wiggins; Stephen H Leppla
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

5.  Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Authors:  Cesare Colasante; Ornella Rossetto; Laura Morbiato; Marco Pirazzini; Jordi Molgó; Cesare Montecucco
Journal:  Mol Neurobiol       Date:  2013-03-08       Impact factor: 5.590

6.  Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy.

Authors:  Dennis J Yoon; Kevin Y Chen; André M Lopes; April A Pan; Joseph Shiloach; Anne B Mason; Daniel T Kamei
Journal:  J Theor Biol       Date:  2017-01-06       Impact factor: 2.691

7.  Intracellular trafficking of AIP56, an NF-κB-cleaving toxin from Photobacterium damselae subsp. piscicida.

Authors:  Liliana M G Pereira; Rute D Pinto; Daniela S Silva; Ana R Moreira; Christoph Beitzinger; Pedro Oliveira; Paula Sampaio; Roland Benz; Jorge E Azevedo; Nuno M S dos Santos; Ana do Vale
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

8.  Refined structure of monomeric diphtheria toxin at 2.3 A resolution.

Authors:  M J Bennett; D Eisenberg
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

9.  Pore formation by tetanus toxin, its chain and fragments in neuronal membranes and evaluation of the underlying motifs in the structure of the toxin molecule.

Authors:  J Beise; J Hahnen; B Andersen-Beckh; F Dreyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

10.  Tetanus toxin L chain is processed by major histocompatibility complex class I and class II pathways and recognized by CD8+ or CD4+ T lymphocytes.

Authors:  I Kerblat; S Tongiani-Dahshan; C Aude-Garcia; M Villiers; C Drouet; P N Marche
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.